MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2018 International Congress

    Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series

    C. Wang, E. Wang, H. Lei (Tucson, AZ, USA)

    Objective: To report increased risks of Botulinum Toxin Injection for cervical dystonia and migraine in patients with Hypermobility Ehlers Danlos Syndrome. Background: Ehlers-Danlos syndrome (EDS)…
  • 2018 International Congress

    Stop Signal Reaction Time (SSRT) in Dystonia and its Correction after Botulinum Toxin Treatment

    A. Roy, S. Choudhury, R. Singh, K. Chatterjee, B. Mondal, J. Ganguly, M. Baker, S. Baker, H. Kumar (Kolkata, India)

    Objective: • To compare Stop Signal Reaction Time (SSRT) among patients with Hyperkinetic Movement Disorders and Healthy participants. • To explore the effect of Botulinum…
  • 2018 International Congress

    Botulinum Toxin Injections in Upper Limb Tremor

    W. Fung, M. Ligtermoet, K. Bertram, D. Williams, J. Kamel (Melbourne, Australia)

    Objective: To prospectively assess the outcome of patients receiving botulinum toxin (BoNT) injections for upper limb tremor refractory to oral medications. Background: Upper limb tremor…
  • 2018 International Congress

    Effects of a combined approach with botulinum toxin (BONT) and motor-learning techniques (MLT) on sensori-motor functional connectivity in patients with cervical dystonia (CD)

    A. Castagna, M. Cabinio, M. Ramella, L. Magistrelli, M. Laganà, F. Baglio (Milano, Italy)

    Objective: Aim of this study is to evaluate sensori-motor connectivity associated with a multimodal BoNT/MLT teratment in CD patients using advanced Resonance Imaging (MRI) techniques.…
  • 2018 International Congress

    Postural Stability in Blepharospasm and the Effects of Botulinum Toxin Therapy

    M. Balal, T. Demir, M. Erdem, M. Demirkiran (Adana, Turkey)

    Objective: To determine (1) how blepharospasm effects postural stability and (2) to evaluate the efficacy of botulinum toxin therapy (BoNT-A) on static balance in patients…
  • 2018 International Congress

    Prevalence and Correlates of Anxiety & Depression in Cervical Dystonia

    M. Al Hussona, I. Ndukwe, S. O'Riordan, R. Beck, R. Reilly, M. Hutchinson (Dublin, Ireland)

    Objective: Our aim was to assess the prevalence and severity of mood disorder in our Cervical Dystonia population attending the botulinum toxin clinic and to…
  • 2018 International Congress

    Assessment of cognitive functions, depression-anxiety scales and quality of life in patients and their relatives with Cervical Dystonia and Botulinum Toxin Treatment

    D. Ceylan, S. Erer, M. Zarifoglu, N. Turkes, A. Demiralay (Bursa, Turkey)

    Objective: In this study, we investigated the psychiatric comorbid disorders and quality of life issues such as cognitive dysfunction accompanied by cervical dystonia and accompanying…
  • 2018 International Congress

    How much does botulinum toxin injection interval impact upon patient satisfaction in the routine treatment of cervical dystonia?

    T. Chung, D. Charles, C. Colosimo, V. Misra, P. Maisonobe, S. Om (São Paulo, Brazil)

    Objective: Evaluate the impact of injection interval on satisfaction with botulinum toxin-A (BoNT-A) treatment in cervical dystonia (CD) patients who have been treated for 1…
  • 2018 International Congress

    Who uses guidance techniques for abobotulinumtoxinA injections in the routine management of cervical dystonia?

    V. Misra, R. Trosch, P. Maisonobe, S. Om (London, United Kingdom)

    Objective: Describe the use of injection guidance techniques in different cervical dystonia (CD) patient populations treated in routine practice. Background: The use of injection guidance…
  • 2018 International Congress

    Duration of response with abobotulinumtoxinA in cervical dystonia: Patient distribution results from two open label extension studies

    R. Hauser, D. Truong, M. Jog, D. Grimes, P. Picaut, A. Mann (Tampa, FL, USA)

    Objective: To report patient distribution data for duration of response with abobotulinumtoxinA (aboBoNT-A; Dysport®) from two open-label (OL) studies in patients with cervical dystonia (CD).…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 19
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Carpal Tunnel Syndrome in Patients with Tremor
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley